According to a new study, the interval between doses of the Oxford Covid Vaccine developed by Oxford to be three months instead of six weeks produces a better effect, and this increases the number of people vaccinated immediately. Protection can be provided. The study says that the first dose (Vaccine Doses) can provide up to 76 percent protection. Results of an analysis of a third phase randomized controlled trial published in the journal ‘The Lancet’ suggest that the interval between doses can be safely extended to three months. According to the researchers, this method of dosage is beneficial, since the supply of vaccines is limited initially and doing so may lead to more rapid vaccination of large populations of countries.
Researchers also include researchers from Oxford University, UK. The study’s lead author and University of Oxford professor Andrew Pollard said, “Vaccine supplies are likely to be limited, so policy-makers have to decide how to dose as many people as possible in the shortest time possible. To give them health benefits. “
Pollard believes that the policy of initially vaccinating more people with just one dose can provide immediate protection to a large section of the population from the disease, rather than having only half that number vaccinated, especially Places where Oxford vaccine supplies are limited. He said, “In the long term, a second dose should ensure long-term immunity.”
From this study, researchers tried to understand the effect of varying intervals on safety after the second dose. They combined data from clinical trials in Britain, Brazil and South Africa, which included a total of 17,178 adult participants. Researchers have estimated the effect of one or two doses of the vaccine to reduce Kovid-19 cases.
(This news has not been edited by the NewsBust team. It is published directly from the Syndicate feed.)